In the last 12 months, insiders at Repare Therapeutics Inc. ($RPTX) filed 110 transactions with the SEC: 9 open-market purchases totaling $9,071,242 and 27 sales totaling $269,525. Net insider sentiment: net buying.
Repare Therapeutics Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- BVF PARTNERS L P/IL (TenPercentOwner) — 12 transactions totaling $9,071,242
- Zinda Michael (EVP, Chief Scientific Officer) — 5 transactions totaling $125,974
- Koehler Maria (EVP, Chief Medical Officer) — 6 transactions totaling $98,755
- Segal Lloyd Mitchell (PRESIDENT AND CEO) — 10 transactions totaling $85,179
- Forte Steve (EVP, CHIEF FINANCIAL OFFICER) — 17 transactions totaling $26,855
View all SEC Filings for Repare Therapeutics Inc. (RPTX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 28, 2026 | BVF PARTNERS L P/IL | TenPercentOwner | U | Common Shares, no par value | 5309432 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 12.33% |
| Jan. 28, 2026 | BVF PARTNERS L P/IL | TenPercentOwner | U | Common Shares, no par value | 4308573 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 10.01% |
| Jan. 28, 2026 | BVF PARTNERS L P/IL | TenPercentOwner | U | Common Shares, no par value | 548938 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 1.28% |
| Jan. 28, 2026 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | D | Common Shares | 56786 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.13% |
| Jan. 28, 2026 | Civik Thomas | Not found | D | Common Shares | 7500 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.02% |
| Jan. 28, 2026 | RHOADS ANN D | Not found | D | Common Shares | 4000 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.01% |
| Jan. 28, 2026 | SCHAFER CAROL | Not found | D | Stock Option (right to buy) | 37941 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.09% |
| Jan. 28, 2026 | SCHAFER CAROL | Not found | D | Common Shares | 8000 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.02% |
| Jan. 28, 2026 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | D | Employee Stock Option (right to buy) | 500000 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 1.16% |
| Jan. 28, 2026 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | D | Employee Stock Option (right to buy) | 85000 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.20% |
| Jan. 28, 2026 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | D | Employee Stock Option (right to buy) | 200000 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.46% |
| Jan. 28, 2026 | Alves Sandra Isabelle Barros | SVP, Finance and CAO | D | Employee Stock Option (right to buy) | 24500 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.06% |
| Jan. 28, 2026 | Alves Sandra Isabelle Barros | SVP, Finance and CAO | D | Employee Stock Option (right to buy) | 26000 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.06% |
| Jan. 28, 2026 | Alves Sandra Isabelle Barros | SVP, Finance and CAO | D | Common Shares | 31622 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.07% |
| Jan. 28, 2026 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | D | Employee Stock Option (right to buy) | 325800 | $0.00 | 0.0000 | 43,051,934 | 100.00% | 0.76% |
| April 2, 2025 | Alves Sandra Isabelle Barros | SVP, Finance and CAO | A | Common Shares | 4100 | $0.00 | 29,622.0000 | 42,411,085 | 16.06% | 0.01% |
| April 2, 2025 | Alves Sandra Isabelle Barros | SVP, Finance and CAO | A | Employee Stock Option (right to buy) | 24500 | $0.00 | 24,500.0000 | 42,411,085 | 9999.99% | 0.06% |
| April 2, 2025 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 500000 | $0.00 | 500,000.0000 | 42,411,085 | 9999.99% | 1.18% |
| March 12, 2025 | Segal Lloyd Mitchell | PRESIDENT AND CEO | S | Common Shares | 21179 | $1.14 | 231,952.0000 | 42,411,085 | 8.37% | 0.05% |
| March 12, 2025 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | S | Common Shares | 6884 | $1.14 | 54,786.0000 | 42,411,085 | 11.16% | 0.02% |
| March 12, 2025 | Koehler Maria | EVP, CHIEF MEDICAL OFFICER | S | Common Shares | 3596 | $1.14 | 227,813.0000 | 42,411,085 | 1.55% | 0.01% |
| March 12, 2025 | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Shares | 5611 | $1.14 | 80,297.0000 | 42,411,085 | 6.53% | 0.01% |
| March 4, 2025 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 42,411,085 | 9999.99% | 0.47% |
| March 4, 2025 | Segal Lloyd Mitchell | PRESIDENT AND CEO | A | Common Shares | 40000 | $0.00 | 253,131.0000 | 42,411,085 | 18.77% | 0.09% |
| March 4, 2025 | Segal Lloyd Mitchell | PRESIDENT AND CEO | A | Employee Stock Option (right to buy) | 237000 | $0.00 | 237,000.0000 | 42,411,085 | 9999.99% | 0.56% |
| March 4, 2025 | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | A | Common Shares | 14000 | $0.00 | 85,908.0000 | 42,411,085 | 19.47% | 0.03% |
| March 4, 2025 | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | A | Employee Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 42,411,085 | 9999.99% | 0.18% |
| March 4, 2025 | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | A | Employee Stock Option (right to buy) | 85000 | $0.00 | 85,000.0000 | 42,411,085 | 9999.99% | 0.20% |
| March 4, 2025 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | A | Common Shares | 14000 | $0.00 | 61,670.0000 | 42,411,085 | 29.37% | 0.03% |
| March 4, 2025 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 85000 | $0.00 | 85,000.0000 | 42,411,085 | 9999.99% | 0.20% |
| June 17, 2024 | Molineaux Susan | Not found | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 42,093,293 | 9999.99% | 0.06% |
| June 17, 2024 | Kulkarni Samarth | Not found | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 42,093,293 | 9999.99% | 0.06% |
| June 17, 2024 | Bonita David P | Not found | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 42,093,293 | 9999.99% | 0.06% |
| June 17, 2024 | Civik Thomas | Not found | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 42,093,293 | 9999.99% | 0.06% |
| June 17, 2024 | Stein Steven H | Not found | A | Stock Option (right to buy) | 54000 | $0.00 | 54,000.0000 | 42,093,293 | 9999.99% | 0.13% |
| June 17, 2024 | SCHAFER CAROL | Not found | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 42,093,293 | 9999.99% | 0.06% |
| June 17, 2024 | RHOADS ANN D | Not found | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 42,093,293 | 9999.99% | 0.06% |
| June 17, 2024 | Morrison Briggs | Not found | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 42,093,293 | 9999.99% | 0.06% |
| April 1, 2024 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | S | Common Shares | 789 | $4.61 | 44,775.0000 | 42,093,293 | 1.73% | 0.00% |
| March 28, 2024 | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Shares | 450 | $4.64 | 72,318.0000 | 42,093,293 | 0.62% | 0.00% |
| April 1, 2024 | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Shares | 410 | $4.66 | 71,908.0000 | 42,093,293 | 0.57% | 0.00% |
| March 28, 2024 | Koehler Maria | EVP, CHIEF MEDICAL OFFICER | S | Common Shares | 500 | $4.64 | 231,709.0000 | 42,093,293 | 0.22% | 0.00% |
| April 1, 2024 | Koehler Maria | EVP, CHIEF MEDICAL OFFICER | S | Common Shares | 300 | $4.66 | 231,409.0000 | 42,093,293 | 0.13% | 0.00% |
| March 28, 2024 | Segal Lloyd Mitchell | PRESIDENT AND CEO | S | Common Shares | 2650 | $4.62 | 212,727.0000 | 42,093,293 | 1.23% | 0.01% |
| April 1, 2024 | Segal Lloyd Mitchell | PRESIDENT AND CEO | S | Common Shares | 2491 | $4.63 | 210,236.0000 | 42,093,293 | 1.17% | 0.01% |
| March 28, 2024 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | S | Common Shares | 825 | $4.62 | 45,564.0000 | 42,093,293 | 1.78% | 0.00% |
| March 25, 2024 | Segal Lloyd Mitchell | PRESIDENT AND CEO | S | Common Shares | 2650 | $4.79 | 213,843.0000 | 42,093,293 | 1.22% | 0.01% |
| March 25, 2024 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | S | Common Shares | 825 | $4.79 | 43,862.0000 | 42,093,293 | 1.85% | 0.00% |
| March 26, 2024 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | S | Common Shares | 825 | $4.60 | 43,037.0000 | 42,093,293 | 1.88% | 0.00% |
| March 27, 2024 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | S | Common Shares | 825 | $4.62 | 42,212.0000 | 42,093,293 | 1.92% | 0.00% |
| March 25, 2024 | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Shares | 450 | $4.78 | 73,668.0000 | 42,093,293 | 0.61% | 0.00% |
| March 26, 2024 | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Shares | 450 | $4.61 | 73,218.0000 | 42,093,293 | 0.61% | 0.00% |
| March 27, 2024 | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Shares | 450 | $4.62 | 72,768.0000 | 42,093,293 | 0.61% | 0.00% |
| March 25, 2024 | Koehler Maria | EVP, CHIEF MEDICAL OFFICER | S | Common Shares | 500 | $4.78 | 233,209.0000 | 42,093,293 | 0.21% | 0.00% |
| March 26, 2024 | Koehler Maria | EVP, CHIEF MEDICAL OFFICER | S | Common Shares | 500 | $4.60 | 232,709.0000 | 42,093,293 | 0.21% | 0.00% |
| March 27, 2024 | Koehler Maria | EVP, CHIEF MEDICAL OFFICER | S | Common Shares | 500 | $4.62 | 232,209.0000 | 42,093,293 | 0.21% | 0.00% |
| March 26, 2024 | Segal Lloyd Mitchell | PRESIDENT AND CEO | S | Common Shares | 2650 | $4.64 | 211,193.0000 | 42,093,293 | 1.24% | 0.01% |
| March 27, 2024 | Segal Lloyd Mitchell | PRESIDENT AND CEO | S | Common Shares | 2650 | $4.63 | 208,543.0000 | 42,093,293 | 1.25% | 0.01% |
| March 1, 2024 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | A | Common Shares | 14000 | $0.00 | 44,687.0000 | 42,093,293 | 45.62% | 0.03% |
| March 1, 2024 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | A | Employee Stock Option (right to buy) | 85000 | $0.00 | 85,000.0000 | 42,093,293 | 9999.99% | 0.20% |
| March 1, 2024 | Koehler Maria | EVP, CHIEF MEDICAL OFFICER | A | Employee Stock Option (right to buy) | 85000 | $0.00 | 85,000.0000 | 42,093,293 | 9999.99% | 0.20% |
| March 1, 2024 | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | A | Common Shares | 14000 | $0.00 | 74,118.0000 | 42,093,293 | 23.29% | 0.03% |
| March 1, 2024 | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | A | Employee Stock Option (right to buy) | 85000 | $0.00 | 85,000.0000 | 42,093,293 | 9999.99% | 0.20% |
| March 1, 2024 | Segal Lloyd Mitchell | PRESIDENT AND CEO | A | Common Shares | 40000 | $0.00 | 219,143.0000 | 42,093,293 | 22.33% | 0.10% |
| March 1, 2024 | Segal Lloyd Mitchell | PRESIDENT AND CEO | A | Employee Stock Option (right to buy) | 237000 | $0.00 | 237,000.0000 | 42,093,293 | 9999.99% | 0.56% |
| March 1, 2024 | Koehler Maria | EVP, CHIEF MEDICAL OFFICER | A | Common Shares | 14000 | $0.00 | 233,709.0000 | 42,093,293 | 6.37% | 0.03% |
| Dec. 11, 2023 | Koehler Maria | EVP, Chief Medical Officer | M | Employee Stock Option (right to buy) | 20190 | $0.00 | 24,229.0000 | 0 | 45.45% | 0.00% |
| Dec. 11, 2023 | Koehler Maria | EVP, Chief Medical Officer | M | Employee Stock Option (right to buy) | 23556 | $0.00 | 87,691.0000 | 0 | 21.17% | 0.00% |
| Dec. 11, 2023 | Koehler Maria | EVP, Chief Medical Officer | M | Common Shares | 23556 | $2.43 | 219,709.0000 | 0 | 12.01% | 0.00% |
| Dec. 11, 2023 | Koehler Maria | EVP, Chief Medical Officer | M | Common Shares | 20190 | $2.06 | 196,153.0000 | 0 | 11.47% | 0.00% |
| Nov. 15, 2023 | BVF PARTNERS L P/IL | TenPercentOwner | P | Common Shares, no par value | 47712 | $5.00 | 532,795.0000 | 0 | 9.84% | 0.00% |
| Nov. 16, 2023 | BVF PARTNERS L P/IL | TenPercentOwner | P | Common Shares, no par value | 125909 | $5.38 | 4,308,573.0000 | 0 | 3.01% | 0.00% |
| Nov. 16, 2023 | BVF PARTNERS L P/IL | TenPercentOwner | P | Common Shares, no par value | 153693 | $5.38 | 5,309,432.0000 | 0 | 2.98% | 0.00% |
| Nov. 16, 2023 | BVF PARTNERS L P/IL | TenPercentOwner | P | Common Shares, no par value | 16143 | $5.38 | 548,938.0000 | 0 | 3.03% | 0.00% |
| Nov. 15, 2023 | BVF PARTNERS L P/IL | TenPercentOwner | P | Common Shares, no par value | 493337 | $5.00 | 5,155,739.0000 | 0 | 10.58% | 0.00% |
| Nov. 15, 2023 | BVF PARTNERS L P/IL | TenPercentOwner | P | Common Shares, no par value | 390507 | $5.00 | 4,182,664.0000 | 0 | 10.30% | 0.00% |
| Nov. 2, 2023 | BVF PARTNERS L P/IL | TenPercentOwner | P | Common Shares, no par value | 218979 | $3.60 | 4,662,402.0000 | 0 | 4.93% | 0.00% |
| Nov. 2, 2023 | BVF PARTNERS L P/IL | TenPercentOwner | P | Common Shares, no par value | 72479 | $3.60 | 485,083.0000 | 0 | 17.57% | 0.00% |
| Nov. 2, 2023 | BVF PARTNERS L P/IL | TenPercentOwner | P | Common Shares, no par value | 492251 | $3.60 | 3,792,157.0000 | 0 | 14.92% | 0.00% |
| June 8, 2023 | Civik Thomas | Director | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | SCHAFER CAROL | Director | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | RHOADS ANN D | Director | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Morrison Briggs | Director | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Molineaux Susan | Director | A | Stock Option (right to buy) | 76200 | $0.00 | 76,200.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Kulkarni Samarth | Director | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Foley Todd | Director | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Bonita David P | Director | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Zinda Michael | EVP, Chief Scientific Officer | S | Common Shares | 2869 | $12.02 | 60,118.0000 | 0 | 5.01% | 0.00% |
| June 7, 2023 | Zinda Michael | EVP, Chief Scientific Officer | S | Common Shares | 6404 | $12.03 | 62,987.0000 | 0 | 9.23% | 0.00% |
| June 6, 2023 | Zinda Michael | EVP, Chief Scientific Officer | S | Common Shares | 1200 | $12.04 | 69,391.0000 | 0 | 1.70% | 0.00% |
| Jan. 30, 2023 | Segal Lloyd Mitchell | President and CEO | A | Common Shares | 78550 | $0.00 | 179,143.0000 | 0 | 78.09% | 0.00% |
| Jan. 30, 2023 | Koehler Maria | EVP, Chief Medical Officer | A | Employee Stock Option (right to buy) | 119250 | $0.00 | 119,250.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2023 | Forte Steve | EVP, Chief Financial Officer | A | Employee Stock Option (right to buy) | 111050 | $0.00 | 111,050.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2023 | Zinda Michael | EVP, Chief Scientific Officer | A | Employee Stock Option (right to buy) | 97100 | $0.00 | 97,100.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2023 | Zinda Michael | EVP, Chief Scientific Officer | A | Common Shares | 24550 | $0.00 | 70,591.0000 | 0 | 53.32% | 0.00% |
| Jan. 30, 2023 | Koehler Maria | EVP, Chief Medical Officer | A | Common Shares | 26450 | $0.00 | 175,963.0000 | 0 | 17.69% | 0.00% |
| Jan. 30, 2023 | Forte Steve | EVP, Chief Financial Officer | A | Common Shares | 24530 | $0.00 | 30,687.0000 | 0 | 398.41% | 0.00% |
| Jan. 30, 2023 | Segal Lloyd Mitchell | President and CEO | A | Employee Stock Option (right to buy) | 344200 | $0.00 | 344,200.0000 | 0 | 9999.99% | 0.00% |
| Dec. 29, 2022 | Jerel Davis | Director | J | Common Shares | 9561 | $0.00 | 2,369,554.0000 | 0 | 0.40% | 0.00% |
| Dec. 29, 2022 | Jerel Davis | Director | J | Common Shares | 287157 | $0.00 | 2,914,196.0000 | 0 | 8.97% | 0.00% |
| Dec. 29, 2022 | Jerel Davis | Director | J | Common Shares | 2065 | $0.00 | 2,416,750.0000 | 0 | 0.09% | 0.00% |
| Dec. 29, 2022 | Jerel Davis | Director | J | Common Shares | 65957 | $0.00 | 2,350,793.0000 | 0 | 2.73% | 0.00% |
| Dec. 29, 2022 | Jerel Davis | Director | J | Common Shares | 1240 | $0.00 | 2,347,779.0000 | 0 | 0.05% | 0.00% |
| Dec. 29, 2022 | Jerel Davis | Director | J | Common Shares | 21854 | $0.00 | 2,393,670.0000 | 0 | 0.90% | 0.00% |
| Dec. 29, 2022 | Jerel Davis | Director | J | Common Shares | 4721 | $0.00 | 2,355,514.0000 | 0 | 0.20% | 0.00% |
| Dec. 29, 2022 | Jerel Davis | Director | J | Common Shares | 4721 | $0.00 | 2,350,793.0000 | 0 | 0.20% | 0.00% |
| Dec. 29, 2022 | Jerel Davis | Director | J | Common Shares | 3014 | $0.00 | 2,350,793.0000 | 0 | 0.13% | 0.00% |
| Dec. 29, 2022 | Jerel Davis | Director | J | Common Shares | 1866 | $0.00 | 2,414,685.0000 | 0 | 0.08% | 0.00% |
| Dec. 29, 2022 | Jerel Davis | Director | J | Common Shares | 8638 | $0.00 | 2,367,742.0000 | 0 | 0.36% | 0.00% |
| Dec. 29, 2022 | Jerel Davis | Director | J | Common Shares | 62026 | $0.00 | 2,412,819.0000 | 0 | 2.64% | 0.00% |